Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1
Department of Geriatric Medicine, Graduate School of Medicine, University of Tokyo, Tokyo1 13-8655, Japan Obstructive sleep apnea syndrome (OSAS) is one of the most important risk factors of cardiovascular disorders. In the treatment of OSAS, nasal continuous positive airway pressure (nCPAP) has bee...
Saved in:
Published in | Journal of applied physiology (1985) Vol. 94; no. 1; pp. 179 - 184 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Bethesda, MD
Am Physiological Soc
01.01.2003
American Physiological Society |
Subjects | |
Online Access | Get full text |
ISSN | 8750-7587 1522-1601 |
DOI | 10.1152/japplphysiol.00177.2002 |
Cover
Summary: | Department of Geriatric Medicine, Graduate School of
Medicine, University of Tokyo, Tokyo1 13-8655, Japan
Obstructive sleep apnea
syndrome (OSAS) is one of the most important risk factors of
cardiovascular disorders. In the treatment of OSAS, nasal continuous
positive airway pressure (nCPAP) has been widely used and found to be
effective. In the present study, we hypothesized that the
hypoxic stress caused by obstructive sleep apnea would increase
circulating intercellular adhesion molecule-1 (ICAM-1), interleukin-8
(IL-8), and monocyte chemoattractant protein-1 (MCP-1) in untreated
OSAS patients compared with an age-matched control group. In addition,
we hypothesized that nCPAP may decrease OSAS-induced hypoxic stress and
mediators. To examine these hypotheses, we measured circulating ICAM-1
and IL-8 before and after nCPAP therapy in OSAS patients. We observed
that nCPAP decreased apnea, desaturation, and the circulating ICAM-1
and IL-8 levels in OSAS patients. The circulating levels of ICAM-1, IL-8, and MCP-1 in untreated OSAS patients were significantly greater
than those in the controls. These observations suggest that nCPAP
therapy could reduce OSAS-induced hypoxia and generation of
inflammatory mediators. Treatment of OSAS using nCPAP can be, therefore, a potential approach to decrease risk of the progression of
OSAS-associated disorders.
cytokines; cardiovascular disorders; ischemic heart
disease; desaturation magnitude; hypoxic stress; intracellular adhesion
molecule-1; monocyte chemoattractant protein-1; interleukin-8 |
---|---|
Bibliography: | SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 8750-7587 1522-1601 |
DOI: | 10.1152/japplphysiol.00177.2002 |